-
The Year's Biggest Healthcare Conference Commences This Week; Here's What You Need To Know
Monday, January 9, 2017 - 7:33am | 817Read More...The 35th JPMorgan Chase & Co. (NYSE: JPM) Healthcare Conference gets underway on January 9 and will go on until January 13. Touted as the life science industry's largest conferences of the year, the event showcases innovations of healthcare companies, which are out to scout for their next...
-
Shares Of Merck Dip Lower Following Q4 Print
Wednesday, February 3, 2016 - 9:42am | 223Read More...Shares of Merck & Co., Inc. (NYSE: MRK) were trading lower by more than 2 percent early Wednesday morning after the company released its fourth quarter results. Merck earned $0.93 per share in the fourth quarter on revenue of $10.21 billion. Wall Street analysts were expecting the company...
-
Merck CEO: Using Keytruda Could Extend Patient's Life By 13 Months On Average
Monday, December 21, 2015 - 2:43pm | 166Read More...Speaking to Fox Business Network, Merck & Co., Inc. (NYSE: MRK)'s CEO Kenneth Frazier discussed the company's Keytruda drug that is used to treat patients suffering from lung cancer. Frazier, citing recent data from studies, said that using Keytruda could extend the life of a...
-
These Three Pharma Giants Just Crushed Earnings
Tuesday, October 27, 2015 - 10:09am | 635Read More...Investors have been anxiously awaiting earnings report from pharmaceutical giants to ease ongoing concerns. Pfizer Inc. (NYSE: PFE), Bristol-Myers Squibb Co (NYSE: BMY), and Merck & Co., Inc. (NYSE: MRK) reported their quarterly Tuesday morning results. Shares of all three names were...
-
Merck Shares Soar After Announcing More Job Cuts
Tuesday, October 1, 2013 - 2:28pm | 404Read More...Drugmaker Merck & Co. (NYSE: MRK) saw shares rise 2.5 percent in afternoon trading as it announced 8,500 job cuts and touted savings of $2.5 billion as part of a global initiative “to sharpen its commercial and research and development focus.” Merck CEO Kenneth C. Frazier said in a news...
